RTSN Award Disclosure
Berger Franklin M · SEC Form 4 · Filed Oct 8, 2026
Award
Calculated transaction value
$0
Berger Franklin M Director
RTSN
Transaction date
Oct 8, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed same day
RTSN daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 5,636 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-108188
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Retension Pharmaceuticals, Inc. RTSN Current | Award | Oct 8, 2026 | $0 |